Sterling Capital Management LLC Acquires 34,975 Shares of Natera, Inc. $NTRA

Posted by Brian Himes on Jun 27th, 2026

Sterling Capital Management LLC boosted its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 49.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,222 shares of the medical research company’s stock after purchasing an additional 34,975 shares during the period. Sterling Capital Management LLC’s holdings in Natera were worth $21,243,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Robinhood Asset Management LLC purchased a new position in shares of Natera during the fourth quarter valued at about $12,981,000. Systrade AG purchased a new stake in Natera in the fourth quarter worth about $11,454,000. Quantbot Technologies LP purchased a new stake in Natera in the third quarter worth about $1,069,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Natera by 5.7% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 159,166 shares of the medical research company’s stock valued at $25,621,000 after acquiring an additional 8,630 shares in the last quarter. Finally, J. Safra Sarasin Holding AG bought a new stake in Natera during the 4th quarter valued at approximately $2,825,000. Institutional investors own 99.90% of the company’s stock.

Insider Activity

In other news, CEO Steven Leonard Chapman sold 41,124 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $221.03, for a total transaction of $9,089,637.72. Following the transaction, the chief executive officer directly owned 108,743 shares of the company’s stock, valued at $24,035,465.29. This represents a 27.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Solomon Moshkevich sold 3,405 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $203.69, for a total value of $693,564.45. Following the sale, the insider directly owned 142,295 shares in the company, valued at $28,984,068.55. This trade represents a 2.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 178,872 shares of company stock valued at $39,415,896. Corporate insiders own 5.05% of the company’s stock.

Wall Street Analysts Forecast Growth

NTRA has been the subject of several research reports. JPMorgan Chase & Co. increased their target price on Natera from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Natera in a research report on Tuesday, April 21st. Wolfe Research initiated coverage on Natera in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $260.00 price objective for the company. BTIG Research set a $275.00 price objective on Natera and gave the stock a “buy” rating in a report on Wednesday. Finally, Evercore reissued an “outperform” rating and set a $270.00 price objective on shares of Natera in a research report on Friday, May 8th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $259.22.

Check Out Our Latest Stock Analysis on Natera

Natera Stock Up 0.4%

Shares of NASDAQ NTRA opened at $261.91 on Friday. Natera, Inc. has a twelve month low of $131.81 and a twelve month high of $271.47. The firm has a market cap of $37.51 billion, a P/E ratio of -160.68 and a beta of 1.56. The company has a 50 day moving average of $212.73 and a 200 day moving average of $215.87.

Natera Profile

(Free Report)

Natera is a global diagnostics company that develops and commercializes cell-free DNA and other genetic testing technologies for clinical applications. The company focuses on three principal areas: reproductive health (including non-invasive prenatal testing and carrier screening), oncology (tumor-informed assays for minimal residual disease and recurrence monitoring), and organ transplantation (cell-free DNA tests to detect allograft injury). Natera combines laboratory testing, proprietary bioinformatics, and clinical reporting to deliver personalized genetic information to clinicians and patients.

Key product offerings include Panorama, a non-invasive prenatal test that screens for fetal chromosomal abnormalities and select single-gene conditions; Horizon carrier screening for inherited conditions; Signatera, a personalized, tumor-informed assay used for detecting minimal residual disease and monitoring treatment response in cancer patients; and Prospera, a donor-derived cell-free DNA test used to assess the risk of organ rejection.

Sterling Capital Management LLC Acquires 34,975 Shares of Natera, Inc. $NTRA

Insider Activity

Wall Street Analysts Forecast Growth

Natera Stock Up 0.4%

Natera Profile

See Also

You might be interested in: